78 related articles for article (PubMed ID: 15068800)
1. Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
Ponnuraj K; Xu Y; Macon K; Moore D; Volanakis JE; Narayana SV
Mol Cell; 2004 Apr; 14(1):17-28. PubMed ID: 15068800
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of complement inhibition by a mosquito protein revealed through cryo-EM.
Andersen JF; Lei H; Strayer EC; Pham V; Ribeiro JMC
Commun Biol; 2024 May; 7(1):649. PubMed ID: 38802531
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for engagement by complement factor H of C3b on a self surface.
Morgan HP; Schmidt CQ; Guariento M; Blaum BS; Gillespie D; Herbert AP; Kavanagh D; Mertens HD; Svergun DI; Johansson CM; Uhrín D; Barlow PN; Hannan JP
Nat Struct Mol Biol; 2011 Apr; 18(4):463-70. PubMed ID: 21317894
[TBL] [Abstract][Full Text] [Related]
4. A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism.
Andersen JF; Lei H; Strayer EC; Kanai T; Pham V; Pan XZ; Alvarenga PH; Gerber GF; Asojo OA; Francischetti IMB; Brodsky RA; Valenzuela JG; Ribeiro JMC
Blood; 2023 Jun; 141(25):3109-3121. PubMed ID: 36947859
[TBL] [Abstract][Full Text] [Related]
5. Species specificity of the complement inhibitor compstatin investigated by all-atom molecular dynamics simulations.
Tamamis P; Morikis D; Floudas CA; Archontis G
Proteins; 2010 Sep; 78(12):2655-67. PubMed ID: 20589629
[TBL] [Abstract][Full Text] [Related]
6. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
Proc Natl Acad Sci U S A; 2009 Jan; 106(3):882-7. PubMed ID: 19136636
[TBL] [Abstract][Full Text] [Related]
7. Factor B structure provides insights into activation of the central protease of the complement system.
Milder FJ; Gomes L; Schouten A; Janssen BJ; Huizinga EG; Romijn RA; Hemrika W; Roos A; Daha MR; Gros P
Nat Struct Mol Biol; 2007 Mar; 14(3):224-8. PubMed ID: 17310251
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Listeria Monocytogenes HtrA Protease with Camostat, Gabexate and Nafamostat Mesylates and the Binding Mode of the Inhibitors.
C AM; Wessler S; Ponnuraj K
Protein J; 2023 Aug; 42(4):343-354. PubMed ID: 37093417
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular weight inhibitors of the alternative complement pathway.
Schubart A; Flohr S; Junt T; Eder J
Immunol Rev; 2023 Jan; 313(1):339-357. PubMed ID: 36217774
[TBL] [Abstract][Full Text] [Related]
10. Novel Insights into Factor D Inhibition.
Gavriilaki E; Papakonstantinou A; Agrios KA
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806224
[TBL] [Abstract][Full Text] [Related]
11. NBCZone: Universal three-dimensional construction of eleven amino acids near the catalytic nucleophile and base in the superfamily of (chymo)trypsin-like serine fold proteases.
Denesyuk AI; Johnson MS; Salo-Ahen OMH; Uversky VN; Denessiouk K
Int J Biol Macromol; 2020 Jun; 153():399-411. PubMed ID: 32151723
[TBL] [Abstract][Full Text] [Related]
12. Analysis of protein missense alterations by combining sequence- and structure-based methods.
Gyulkhandanyan A; Rezaie AR; Roumenina L; Lagarde N; Fremeaux-Bacchi V; Miteva MA; Villoutreix BO
Mol Genet Genomic Med; 2020 Apr; 8(4):e1166. PubMed ID: 32096919
[TBL] [Abstract][Full Text] [Related]
13. Role of the I16-D194 ionic interaction in the trypsin fold.
Stojanovski BM; Chen Z; Koester SK; Pelc LA; Di Cera E
Sci Rep; 2019 Dec; 9(1):18035. PubMed ID: 31792294
[TBL] [Abstract][Full Text] [Related]
14. Surface loops of trypsin-like serine proteases as determinants of function.
Goettig P; Brandstetter H; Magdolen V
Biochimie; 2019 Nov; 166():52-76. PubMed ID: 31505212
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.
Schubart A; Anderson K; Mainolfi N; Sellner H; Ehara T; Adams CM; Mac Sweeney A; Liao SM; Crowley M; Littlewood-Evans A; Sarret S; Wieczorek G; Perrot L; Dubost V; Flandre T; Zhang Y; Smith RJH; Risitano AM; Karki RG; Zhang C; Valeur E; Sirockin F; Gerhartz B; Erbel P; Hughes N; Smith TM; Cumin F; Argikar UA; Haraldsson B; Mogi M; Sedrani R; Wiesmann C; Jaffee B; Maibaum J; Flohr S; Harrison R; Eder J
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7926-7931. PubMed ID: 30926668
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.
Estelius J; Lengqvist J; Ossipova E; Idborg H; Le Maître E; Andersson MLA; Brundin L; Khademi M; Svenungsson E; Jakobsson PJ; Lampa J
Arthritis Res Ther; 2019 Feb; 21(1):60. PubMed ID: 30770760
[TBL] [Abstract][Full Text] [Related]
17. Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.
Kenny LC; Kell DB
Front Med (Lausanne); 2017; 4():239. PubMed ID: 29354635
[TBL] [Abstract][Full Text] [Related]
18. Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.
Ricklin D; Reis ES; Mastellos DC; Gros P; Lambris JD
Immunol Rev; 2016 Nov; 274(1):33-58. PubMed ID: 27782325
[TBL] [Abstract][Full Text] [Related]
19. Biology and structure of leukocyte β
Arnaout MA
F1000Res; 2016; 5():. PubMed ID: 27781085
[TBL] [Abstract][Full Text] [Related]
20. FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor.
Jusko M; Miedziak B; Ermert D; Magda M; King BC; Bielecka E; Riesbeck K; Eick S; Potempa J; Blom AM
J Immunol; 2016 Oct; 197(8):3245-3259. PubMed ID: 27638863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
